The Re-imagining TB Care (RTC) initiative was originally conceptualized at the first TB Innovation Summit, which was co-organized by the Stop TB Partnership, Johnson & Johnson, United Nations Foundation, Global Fund to Fight AIDS, Tuberculosis and Malaria (“Global Fund”), and the World Economic Forum, in advance of the first United Nations High-Level Meeting (UNHLM) on tuberculosis (TB) in September 2018. Please see https://www.youtube.com/watch?v=7isfwwgfVFc and https://www.stoptb.org/news/global-health-and-business-leaders-pledge-major-commitments-to-end-tuberculosis for additional information.

The RTC initiative aims to transform when, where, and how healthcare services are accessed and delivered for TB, TB co-morbidities, and other respiratory-based illnesses in TB affected countries. In short, how do we make it as convenient and easy as possible for TB affected people and communities to receive care? To achieve this mission, the three primary, interlinked goals and objectives will be to:

  • Goal 1: Catalyze neighborhood-/home-based care for TB, TB co-morbidities, and other respiratory based illnesses in a small co-hort of TB affected countries;
  • Goal 2 (Accelerator for Impact (a4i)): Accelerate the sustainable roll-out of innovations, particularly DTx, that will facilitate and augment neighborhood-/home-based case for TB, TB co-morbidities, and other respiratory based illnesses in a small co-hort of TB affected countries; and
  • Goal 3: Enhance and optimize existing electronic health records (EHR) and information management systems for TB, TB co-morbidities, and other respiratory based illnesses in a small co-hort of TB affected countries.

In addition to highlighting how the conceptualization and implementation of the RTC initiative has been a collaborative effort with key in-country and global stakeholders, partners, and end-users and across the various constituencies, teams, and initiatives at the Stop TB Partnership, the External Affairs & Strategic Initiatives (EASI) team would like to acknowledge United States Agency for International Development’s (USAID) overall funding to the organization and catalytic funding from US Centers for Disease Control & Prevention (CDC), which contributed to the development and initial implementation of the initiative. We would also like to recognize the new funding from Korea International Cooperation Agency (KOICA), particularly related to a4i.

For additional information regarding the RTC initiative, please e-mail EASI@stoptb.org.